We are live on ! Find out more
IART icon

Integra LifeSciences

207 hedge funds and large institutions have $1.04B invested in Integra LifeSciences in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 65 increasing their positions, 77 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $897M → $1.04B (+$147M)

0% less funds holding

Funds holding: 208207 (-1)

0.57% less ownership

Funds ownership: 94.06%93.5% (-0.57%)

3% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 33

16% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 77

Holders
207
Holders Change
-1
Holders Change %
-0.48%
% of All Funds
2.72%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
32
Increased
65
Reduced
77
Closed
33
Calls
$408K
Puts
Net Calls
+$408K
Net Calls Change
+$68K
Name Holding Trade Value Shares
Change
Change in
Stake
SO
76
STRS Ohio
Ohio
$701K -$42.5K -3,100 -6%
Thrivent Financial for Lutherans
77
Thrivent Financial for Lutherans
Minnesota
$693K -$588K -42,938 -47%
Fisher Asset Management
78
Fisher Asset Management
Washington
$676K
BHCM
79
Brevan Howard Capital Management
Jersey
$622K +$594K +43,388 New
Jennison Associates
80
Jennison Associates
New York
$614K +$587K +42,841 New
CC
81
Clearline Capital
New York
$614K
SDIC
82
South Dakota Investment Council
South Dakota
$613K -$43.8K -3,200 -7%
BCI
83
Brinker Capital Investments
Pennsylvania
$606K +$6.1K +445 +1%
MIM
84
MetLife Investment Management
New Jersey
$588K
SI
85
Sapience Investments
California
$573K -$2.45M -178,995 -82%
AAP
86
Arax Advisory Partners
Colorado
$564K +$535K +39,064 +11,946%
Susquehanna International Group
87
Susquehanna International Group
Pennsylvania
$551K -$647K -47,200 -55%
SOADOR
88
State of Alaska Department of Revenue
Alaska
$547K -$1.37M -100,071 -72%
Capital Fund Management (CFM)
89
Capital Fund Management (CFM)
France
$535K +$27.4K +1,997 +6%
ETC
90
Exchange Traded Concepts
Oklahoma
$533K -$31.8K -2,322 -6%
CMF
91
Counterpoint Mutual Funds
California
$533K +$46.1K +3,368 +10%
Creative Planning
92
Creative Planning
Kansas
$521K +$277K +20,221 +125%
Janus Henderson Group
93
Janus Henderson Group
United Kingdom
$484K
HT
94
Headlands Technologies
Illinois
$469K +$257K +18,742 +134%
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$461K -$24.6K -1,798 -5%
Citigroup
96
Citigroup
New York
$457K -$486K -35,471 -53%
II
97
Inspire Investing
Idaho
$451K -$3.48K -254 -0.8%
Mirae Asset Global ETFs Holdings
98
Mirae Asset Global ETFs Holdings
Hong Kong
$451K -$72.5K -5,291 -14%
LSERS
99
Louisiana State Employees Retirement System
Louisiana
$441K -$5.48K -400 -1%
Verition Fund Management
100
Verition Fund Management
Connecticut
$436K -$1.92M -140,381 -82%

IART Hedge Fund Activity: Q3 2025 in Review

207 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2025, worth a combined $1.04B — up 16% from $897M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of IART and 32 opened new positions — a net loss of 1 holder — while 77 trimmed existing stakes and 65 added.

The largest buyer was Kent Lake PR, opening a new position worth an estimated $10.3M. The largest seller was Assenagon Asset Management, cutting an estimated $10.1M.

  • 207 institutional investors held Integra LifeSciences (IART) as of Q3 2025, down from 208 in Q2 2025.
  • Funds reported $1.04B of Integra LifeSciences stock for Q3 2025, up 16% quarter-over-quarter.
  • 32 funds opened new Integra LifeSciences positions in Q3 2025 and 33 closed out, a net change of -1 holder.
  • The largest Integra LifeSciences buyer in Q3 2025 was Kent Lake PR, an estimated $10.3M added.
  • The largest Integra LifeSciences seller in Q3 2025 was Assenagon Asset Management, an estimated $10.1M sold.

Based on aggregated 13F filings for Q3 2025.